131 related articles for article (PubMed ID: 1728075)
1. Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors.
Søreide O; Berstad T; Bakka A; Schrumpf E; Hanssen LE; Engh V; Bergan A; Flatmark A
Surgery; 1992 Jan; 111(1):48-54. PubMed ID: 1728075
[TBL] [Abstract][Full Text] [Related]
2. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.
Hellman P; Lundström T; Ohrvall U; Eriksson B; Skogseid B; Oberg K; Tiensuu Janson E; Akerström G
World J Surg; 2002 Aug; 26(8):991-7. PubMed ID: 12016480
[TBL] [Abstract][Full Text] [Related]
3. Description of patients with midgut carcinoid tumours: clinical database from a Danish centre.
Nykjaer KM; Grønbaek H; Nielsen DT; Christiansen P; Astrup LB
In Vivo; 2007; 21(4):679-84. PubMed ID: 17708366
[TBL] [Abstract][Full Text] [Related]
4. Cytoreductive surgery in patients with advanced-stage carcinoid tumors.
Gulec SA; Mountcastle TS; Frey D; Cundiff JD; Mathews E; Anthony L; O'Leary JP; Boudreaux JP
Am Surg; 2002 Aug; 68(8):667-71; discussion 671-2. PubMed ID: 12206599
[TBL] [Abstract][Full Text] [Related]
5. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
6. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
Chambers AJ; Pasieka JL; Dixon E; Rorstad O
Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
[TBL] [Abstract][Full Text] [Related]
7. Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma: how many are too many?
Yan DB; Clingan P; Morris DL
Cancer; 2003 Jul; 98(2):320-30. PubMed ID: 12872352
[TBL] [Abstract][Full Text] [Related]
8. Metastatic neuroendocrine hepatic tumors: resection improves survival.
Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
[TBL] [Abstract][Full Text] [Related]
9. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
10. Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival.
Givi B; Pommier SJ; Thompson AK; Diggs BS; Pommier RF
Surgery; 2006 Dec; 140(6):891-7; discussion 897-8. PubMed ID: 17188135
[TBL] [Abstract][Full Text] [Related]
11. Management of hepatic metastasis of gastrointestinal carcinoid tumors.
Landry CS; Scoggins CR; McMasters KM; Martin RC
J Surg Oncol; 2008 Mar; 97(3):253-8. PubMed ID: 18264984
[TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
14. Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.
Kölby L; Persson G; Franzén S; Ahrén B
Br J Surg; 2003 Jun; 90(6):687-93. PubMed ID: 12808615
[TBL] [Abstract][Full Text] [Related]
15. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
16. Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis.
Reddy SK; Barbas AS; Marroquin CE; Morse MA; Kuo PC; Clary BM
J Am Coll Surg; 2007 Mar; 204(3):372-82. PubMed ID: 17324770
[TBL] [Abstract][Full Text] [Related]
17. Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases.
Burke AP; Thomas RM; Elsayed AM; Sobin LH
Cancer; 1997 Mar; 79(6):1086-93. PubMed ID: 9070484
[TBL] [Abstract][Full Text] [Related]
18. Aggressive surgery for metastatic liver neuroendocrine tumors.
Norton JA; Warren RS; Kelly MG; Zuraek MB; Jensen RT
Surgery; 2003 Dec; 134(6):1057-63; discussion 1063-5. PubMed ID: 14668741
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.
Gillams A; Cassoni A; Conway G; Lees W
Abdom Imaging; 2005; 30(4):435-41. PubMed ID: 15759207
[TBL] [Abstract][Full Text] [Related]
20. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
